SYTRA-100 Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SYTRA-100
Itraconazole 100mg
SYTRA-100 (Itraconazole 100mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SYTRA-100 deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SYTRA-100 features Itraconazole 100mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Prescribed in our outpatient depart for SYTRA-100
SYTRA-100 has been prescribed in our outpatient department for over eight months, providing dependable relief from acute discomfort without noticeable lethargy. Bottles and blister strips feature secure tamper-resistant seals that chemists and patients appreciate. Patients frequently remark on the rapid symptomatic comfort and ease of taking this formulation.
Questions Regarding SYTRA-100
What is the therapeutic indication and composition of SYTRA-100?
SYTRA-100 contains Itraconazole 100mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SYTRA-100?
SYTRA-100 is supplied in tamper-evident 10 x 10 Blister Pack / 30 Softgels Bottle, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SYTRA-100?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SYTRA-100 along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SYTRA-100 is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Capsules & Softgel
View all Capsules & Softgel →
CEEVIT-Q10
CO-Enzyme Q10 + Lycopene + L-Arginine + Wheat-Germ oil + Omega-3 Fatty Acid(EPA & DHA) + Piperine + Caroteniods + Vitamins & Minerals
SBCOFF SOFTGEL
Dextromethorphan Hydrobromide 10mg + Chlorpheniramine Maleate 2mg + Phenylephrine Hydrochloride 5mg
